Suchergebnisse - "Yong, Kwee"

PubPharm (375)

1

Diagnosis and management of smouldering myeloma : A British Society for Haematology Good Practice Paper

enthalten in: British journal of haematology | 2024

von Hughes, D. | Yong, K. | Ramasamy, K. | +6

2

Challenges in designing and running smouldering myeloma interventional clinical trials

enthalten in: EJHaem | 2024

von Lecat, C. | Boyle, E. | Hughes, D. | +5

3

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma : results from the NCRI Myeloma X (intensive) trial

enthalten in: Bone marrow transplantation | 2024

von de Tute, R. | Cook, G. | Cairns, D. | +12

4

Chimeric Antigen Receptor

enthalten in: Europäisches Patentamt | 2024

von PULÉ MARTIN | YONG KWEE | LEE LYDIA | +1

5

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma : Long-term outcomes in the Phase 3 IKEMA study

enthalten in: Hematological oncology | 2024

von Facon, T. | Moreau, P. | Špicka, I. | +9

6

Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies

enthalten in: Cancer research | 2024

von Hagos, Y. | Lecat, C. | Patel, D. | +9

7

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

enthalten in: Frontiers in oncology | 2024

von Galas-Filipowicz, D. | Chavda, S. | Gong, J. | +3

8

Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma : Long‐term outcomes in the Phase 3 IKEMA study

enthalten in: Hematological Oncology | 2024

von Facon, T. | Moreau, P. | Špicka, I. | +9

9

Correction : Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

enthalten in: Blood cancer journal | 2023

von Martin, T. | Dimopoulos, M. | Mikhael, J. | +18

ErratumFor: Blood Cancer J. 2023 May 9;13(1):72. - PMID 37156782

10

Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma

enthalten in: British journal of haematology | 2023

von Correia, N. | Dowling, E. | Popat, R. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]